Preclinical In Vivo Evaluation of the Safety of a Multi-shRNA-based Gene Therapy Against HIV-1-Reference-Cited by-同舟云学术

Preclinical In Vivo Evaluation of the Safety of a Multi-shRNA-based Gene Therapy Against HIV-1

Published:2013 Issue: Volume:2 Page:e120
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Centlivre Mireille,Legrand Nicolas,Klamer Sofieke,Liu Ying Poi,Eije Karin Jasmijn von,Bohne Martino,Rijnstra Esther Siteur-van,Weijer Kees,Blom Bianca,Voermans Carlijn,Spits Hergen,Berkhout Ben

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference53 articles.

1. Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy;Yukl;AIDS,2010

2. Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: a randomized 48-week study;Llibre;Antivir Ther (Lond),2012

3. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells;Siliciano;Nat Med,2003

4. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation;Hütter;N Engl J Med,2009

5. Evidence for the cure of HIV infection by CCR5?32/?32 stem cell transplantation;Allers;Blood,2011

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene therapy to cure HIV infection;Virologie;2023-10

2. Gene therapy to cure HIV infection;Virologie;2023-10

3. The discovery and development of RNA-based therapies for treatment of HIV-1 infection;Expert Opinion on Drug Discovery;2022-09-15

4. Biomaterials in Gene Delivery;Functional Biomaterials;2022

5. The HIV Reservoir and Cure and Remission Strategies;Fundamentals of HIV Medicine 2021;2021-06